Online Appointment

Age-related macular degeneration

Age-related macular degeneration2026-05-18T09:43:33+02:00

Age-related macular degeneration (AMD) is a disease of the center of the retina. It affects the so-called macula, the “point of sharpest vision.” This disease involves a loss of function in the sensory cells, leading to vision loss in the center of the visual field. While reading ability decreases and recognizing faces becomes more difficult, the ability to orient oneself externally (peripheral vision) is generally preserved.

The two forms of AMD

    • Dry AMD (approx. 80% of cases): Metabolic deposits, known as drusen, form under the retina. The retina and the underlying pigment epithelium become thinner over time. Since this process is gradual and the other eye often compensates for the visual impairment for a long time, dry AMD frequently remains unnoticed for years.
    • Wet AMD: In this case, abnormal blood vessels grow from deeper layers under the retina. Because these vessels are leaky, fluid or blood escapes. The macula swells (macular edema). A typical warning sign is metamorphopsia: straight lines (e.g., window frames or tile joints) suddenly appear distorted or wavy. In these cases, vision can deteriorate very quickly, which is why immediate treatment by an ophthalmologist is vital for preserving eyesight.

We recommend daily self-monitoring for AMD patients using the Amsler grid (a simple grid of lines). As soon as you notice that lines appear distorted or dark spots appear in the center, please schedule an emergency appointment immediately.

Frequently asked questions about age-related macular degeneration (AMD)

How can macular degeneration be treated?2023-09-20T14:51:55+02:00

For the dry form: There is currently no standard therapy that cures the disease. However, taking special micronutrients (according to the so-called AREDS-2 formula) and consistent UV protection have been proven to delay its progression. For advanced stages (geographic atrophy), the first novel medications are currently undergoing approval or testing. Regular check-ups are important to immediately detect a transition into the wet form.

For the wet form: IVOM therapy is the gold standard here. This involves injecting medications (VEGF inhibitors) directly into the vitreous body of the eye at regular intervals. These active ingredients seal the vessels and can reduce the swelling.

Which medication will I receive?2023-09-20T14:52:15+02:00

Various modern preparations are available (e.g., Eylea®, Lucentis®, Vabysmo®), which are similar in their mode of action. We select the medication individually based on your findings. If a preparation does not show the desired effect, switching to another modern medication is possible and advisable at any time.

Are the costs covered by health insurance?2023-09-20T14:52:35+02:00

In most cases, statutory and private health insurance companies cover the costs of IVOM therapy when it is performed in a public hospital. However, most insurance providers require prior approval for cost coverage if the therapy is to be performed at our practice. Our team will be happy to assist you with the formalities.

Go to Top